Rapid communication: Thyrotropin receptor/thyroglobulin messenger ribonucleic acid in peripheral blood and fine-needle aspiration cytology: Diagnostic synergy for detecting thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 4, 2005, Pages 1921-1924

  Wagner, Kristin ^a   Arciaga, Rosemarie ^a   Siperstein, Allan ^a   Milas, Mira ^a   Warshawsky, Ilka ^a   Reddy, S Sethu K ^a   Gupta, Manjula K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN; THYROTROPIN RECEPTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BLOOD; CANCER RECURRENCE; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THYROID CANCER; THYROID SURGERY; ADOLESCENT; GENETICS; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, THYROTROPIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 19044365077     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1793     Document Type: Article

References (23)

1. Gharib H 1994 Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc 69:44-49
2. Caraway NP, Sneige N, Samaan NA 1993 Diagnostic pitfalls in thyroid fine-needle aspiration: a review of 394 cases. Diagn Cytopathol 9:245-350
3. Ringel MD, Ladenson PW, Levine MA 1998 Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 83:4435-4442
4. Biscolla RPM, Cerutti JM, Maciel RMB 2000 Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood. J Clin Endocrinol Metab 85:3623-3627
5. Fugazzola L, Mihalich A, Persani L, Ceritti N, Reina M, Bonomi E, Ponti D, Mannavola D, Giammona E, Vanucchi G, di Blasio AM, Beck-Peccoz P 2002 Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission. J Clin Endocrinol Metab 87:3201-3208
6. Bellantone R, Lombardi CP, Bossola M, Ferrante A, Princi P, Boscherini M, Maussier L, Salvatori M, Rufini V, Reale F, Talini G, Zelano G, Pontecorvi A 2001 Validity of thyroglobulin mRNA assay in peripheral blood of prospective thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type. Cancer 92:2273-2279
7. Grammatopoulos D, Elliott Y, Smith SC, Brown I, Grieve RJ, Hillhouse EW, Levine MA, Ringel MD 2003 Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer. Mol Pathol 56:162-166
8. Savagner F, Rodien P, Reynier P, Rohmer V, Bigorgne JC, Malthiery Y 2002 Analysis of Tg transcripts by real-time RT-PCR in the blood of thyroid cancer patients. J Clin Endocrinol Metab 87:635-639
9. Ringel MD, Baldushi-Silano PL, Anderson JS, Spencer CA, Silverman J, Sparling YH, Francis GL, Burman K, Wartofsky, Ladenson P, Levine M, Tuttle RM 1999 Quantitative reverse transcription polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma. J Clin Endocrinol Metab 84:4037-4042
10. Eszlinger M, Neumann S, Otto L, Paschke R 2002 Thyroglobulin mRNA quantification in the peripheral blood is not a reliable marker for the follow-up of patients with differentiated thyroid cancer. Eur J Endocrinol 147:575-582
11. Bugalho MJ, Domingues RS, Pinto AC, Garrao A, Catarino AL, Ferreira T, Limbert E, Sobrinho L 2001 Detection of thyroglobulin mRNA transcripts in peripheral blood of individuals with and without thyroid glands: evidence for thyroglobulin expression by blood cells. Eur J Endocrinol 145:409-413
12. Gupta MK, Taguba L, Arciaga R, Siperstein A, Faiman C, Mehta A, Reddy SSK 2002 Detection of circulating thyroid cancer cells by reverse transcription-PCR for thyroid stimulating hormone receptor and thyroglobulin: the importance of primer selection. Clin Chem 48:1862-1865
13. Chinnappa P, Taguba L, Arciaga R, Faiman C, Siperstein A, Mehta AE, Reddy SK, Nasr C, Gupta MK 2004 Detection of TSH-receptor mRNA and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer. J Clin Endocrinol Metab 89:3705-3709
14. Mazzaferri EL 1993 Management of a solitary thyroid nodule. N Engl J Med 328:553-559
15. Goellner JR, Gharib H, Grant CS, Johnson DA 1987 Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol 31:587-590
16. Khurana KK, Troung LD, LiVolsi VA, Baloch ZW 2003 Cytokeratin 19 immunolocalization in cell block preparation of thyroid aspirates. An adjunct to fine-needle aspiration diagnosis of papillary thyroid carcinoma. Arch Pathol Lab Med 127:579-583
17. Sahoo S, Hoda SA, Rosai J, DeLellis RA 2001 Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution. Am J Clin Pathol 116:696-702
18. Sack MJ, Astengo-Osuna C, Lin BT, Battifora H, LiVolsi VA 1997 HBME-1 immunostaining in thyroid fine needle aspirations: a useful marker in the diagnosis of carcinoma. Mod Pathol 10:668-674
19. Casey MB, Lohse CM, Lloyd RV 2003 Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunochemical staining for cytokeratin 19, galectin-3, and HBME-1. Endocr Pathol 14:55-60
20. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW, Tallini G, Kroll TG, Nikiforov YE 2003 Ras point mutations and PAX8-PPARγ rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinomas. J Clin Endocrinol Metab 88:2318-2326
21. Martins L, Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CUM, Kimura ET 2002 Galectin-3 messenger ribonucieic acid and protein are expressed in benign thyroid tumors. J Clin Endocrinol Metab 87:4806-4810
22. Bernet VJ, Anderson J, Vaishnav Y, Solomon B, Adair CF, Saji M, Burman KD, Burch HB, Ringel MD 2002 Determination of galectin-3 messenger ribonucleic acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 87:4792-4796
23. Vasco V, Ferrand M, Cristofaro JD, Carayon P, Henry JF, de Micco C 2003 Specific pattern of Ras oncogene mutations in follicular thyroid tumors. J Clin Endocrinol Metab 88:2745-2752